Drug Shortage Report for ABELCET
| Report ID | 173247 |
| Drug Identification Number | 02231590 |
| Brand name | ABELCET |
| Common or Proper name | Amphotericin B Lipid Complex Injection |
| Company Name | LEADIANT BIOSCIENCES, INC |
| Market Status | DORMANT |
| Active Ingredient(s) | AMPHOTERICIN B |
| Strength(s) | 5MG |
| Dosage form(s) | SUSPENSION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20mL vial |
| ATC code | J02AA |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-09 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-11-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2000 ELLESMERE ROAD SCARBOROUGH, ONTARIO CANADA M1H 2W4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v12 | 2022-11-10 | French | Compare |
| v11 | 2022-11-10 | French | Compare |
| v10 | 2022-11-10 | English | Compare |
| v9 | 2022-11-10 | French | Compare |
| v8 | 2022-11-10 | English | Compare |
| v7 | 2022-11-10 | French | Compare |
| v6 | 2022-11-10 | English | Compare |
| v5 | 2022-11-10 | English | Compare |
| v4 | 2022-11-10 | English | Compare |
| v3 | 2022-11-01 | French | Compare |
| v2 | 2022-11-01 | English | Compare |
| v1 | 2022-11-01 | English | Compare |
Showing 1 to 12 of 12